PhagoMed’s pipeline focuses on treating biofilm-forming bacterial infections. Our phage cocktail candidates are currently all in preclinical development. This section of the website will be updated in the near future.

For now – enjoy this microscopy video of our lead asset “in action”. A cell lawn of multi-drug resistant MRSA is killed by our phage cocktail. Focus on the individual cells and you will see them bursting.